Search

everythinglearnresearchcommunity

for

Search:↓

Migrant and minority communities face higher rates of alopecia due to genetic, environmental, and cultural factors, needing better healthcare access and culturally aware treatments.

PRP and PRF show promise for hair growth but need more research for consistent and safe use.

PRP therapy effectively treats hair loss, wrinkles, scars, ulcers, and skin pigmentation disorders.

Regenerative cosmetics can improve skin and hair by reducing wrinkles, healing wounds, and promoting hair growth.

Exosomal miRNAs from stem cells can help improve skin health and delay aging.

Using minoxidil with laser therapy is more effective for female hair loss than minoxidil alone.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

The new technique effectively treats hairline vitiligo with repigmentation and hair regrowth.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

WNT5A contributes to keloid scars by promoting cell changes through specific signaling pathways.

Keloid scars may form due to changes in skin cell characteristics and specific protein signaling.

miR-26b-5p in macrophage exosomes helps keloids grow.

Combining cryotherapy with steroids reduces keloid size more effectively than steroids alone.

IGF2BP3 and other m6A-related genes are linked to keloid formation and could be potential treatment targets.

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

Keloids on the penis are rare, often triggered by circumcision, and rarely recur after surgery.

We lack effective keloid treatments because their causes are not well understood.

It's generally safe to have most skin procedures after isotretinoin, but avoid aggressive treatments and use a lower dose.

Targeting Midkine can help reduce pain and itching in keloids.

Spontaneous keloids may be linked to nephrogenic systemic fibrosis in dialysis patients.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

Low-dose radiation and certain drugs can inhibit keloid growth, revealing potential treatment targets.

Keloid fibroblasts cause itch and pain by releasing more histamine.

Dermatoscopy helps track scar changes and guide treatment.

Schwann cell and M2 macrophage interactions contribute to keloid growth by increasing matrix deposition.

Non-surgical treatments can significantly reduce keloids in children, with combination therapies being safer and more effective.

Three genes, BMP4, POSTN, and WNT5A, may help treat keloids.

Mechanical tension worsens keloid scars by activating inflammation and fibrosis pathways.